Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS.
about
High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskLipidomics to Assess Omega 3 BioactivityTowards lipidomics of low-abundant species for exploring tumor heterogeneity guided by high-resolution mass spectrometry imagingA Two-Component Regulatory System Impacts Extracellular Membrane-Derived Vesicle Production in Group A StreptococcusHigh-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapyMass spectrometry and inflammation--MS methods to study oxidation and enzyme-induced changes of phospholipids.Regulation of hepatic lipase activity by sphingomyelin in plasma lipoproteins.Sphingomyelin in high-density lipoproteins: structural role and biological function.Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.Multi-level suppression of receptor-PI3K-mTORC1 by fatty acid synthase inhibitors is crucial for their efficacy against ovarian cancer cells.Lipidomics applications in health, disease and nutrition research.Lipidomics in vascular health: current perspectives.Recent advances in lipidomics for disease research.Omics-based approaches to understand mechanosensitive endothelial biology and atherosclerosis.Lipoprotein profiling methodology based on determination of apolipoprotein concentration.Lipidomic profiling of patient-specific iPSC-derived hepatocyte-like cells.An Efficient Glycoblotting-Based Analysis of Oxidized Lipids in Liposomes and a Lipoprotein.Integrated Human Evaluation of the Lysophosphatidic Acid Pathway as a Novel Therapeutic Target in Atherosclerosis.
P2860
Q26775420-43E470EA-67F2-4A6C-8F55-DC2A3919300DQ26786927-8D4017CE-7024-4E8F-8E63-D2E116C9B2E5Q28393497-5881EFE3-20FF-4479-BFEB-78F9059402D7Q29114103-412D0739-A65E-44B6-A59B-58817B86F83BQ34729515-740BA89A-4DD8-47C1-B30C-7BA586086184Q35074231-70391EFE-80A7-44C8-A169-03B4539DADBDQ36032787-F8811B13-ABF2-477E-803F-87A215AD205DQ36820504-3F017657-8905-473E-8289-F8739246AB93Q37592818-8CB634E7-C943-425B-BCC7-6EC866D611B8Q37706959-A912CCD6-B427-4FF6-8BDC-88A34DA308AEQ38111301-F5EC282B-965C-450B-A9BE-B1AAACF2A162Q38537535-7C16833B-13F9-4A1A-BE1A-E7AA214FA447Q38591116-6DD06499-430E-474D-ADEA-9A24C7A9F75FQ38876119-D42CF5F3-8E63-4218-86F5-9797E6348749Q39127566-27D071C6-476A-4406-B807-23D4DF8A217AQ41664781-FAC90180-C567-4E8E-A37E-9F39B5F3C735Q46325442-E2C57E1F-1559-46E1-90B4-AF687B991795Q55668764-2AE6B0C9-BC07-4D3B-B6D0-4CE57E430ABF
P2860
Targeted profiling of atherogenic phospholipids in human plasma and lipoproteins of hyperlipidemic patients using MALDI-QIT-TOF-MS/MS.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@ast
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@en
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@nl
type
label
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@ast
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@en
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@nl
prefLabel
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@ast
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@en
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@nl
P2093
P921
P1433
P1476
Targeted profiling of atheroge ...... nts using MALDI-QIT-TOF-MS/MS.
@en
P2093
Andrea Willfort-Ehringer
Elsie Aldover-Macasaet
Gerald Stübiger
Grazyna Sobal
Katharina Pock
Omar Belgacem
Valery Bochkov
Wolfgang Bicker
P304
P356
10.1016/J.ATHEROSCLEROSIS.2012.06.010
P50
P577
2012-06-23T00:00:00Z